TY - JOUR
T1 - Nanoclay-reinforced HA/alginate scaffolds as cell carriers and SDF-1 delivery-platforms for bone tissue engineering
AU - Erezuma, Itsasne
AU - Lukin, Izeia
AU - Pimenta-Lopes, Carolina
AU - Ventura, Francesc
AU - Garcia-Garcia, Patricia
AU - Reyes, Ricardo
AU - Arnau, Mª Rosa
AU - Delgado, Araceli
AU - Taebnia, Nayere
AU - Kadumudi, Firoz Babu
AU - Dolatshahi-Pirouz, Alireza
AU - Orive, Gorka
N1 - Publisher Copyright:
© 2022 The Author(s)
PY - 2022
Y1 - 2022
N2 - Bone tissue engineering has come on the scene to overcome the difficulties of the current treatment strategies. By combining biomaterials, active agents and growth factors, cells and nanomaterials, tissue engineering makes it possible to create new structures that enhance bone regeneration. Herein, hyaluronic acid and alginate were used to create biologically active hydrogels, and montmorillonite nanoclay was used to reinforce and stabilize them. The developed scaffolds were found to be biocompatible and osteogenic with mMSCs in vitro, especially those reinforced with the nanoclay, and allowed mineralization even in the absence of differentiation media. Moreover, an in vivo investigation was performed to establish the potential of the hydrogels to mend bone and act as cell-carriers and delivery platforms for SDF-1. Scaffolds embedded with SDF-1 exhibited the highest percentages of bone regeneration as well as of angiogenesis, which confirms the suitability of the scaffolds for bone. Although there are a number of obstacles to triumph over, these bioengineered structures showed potential as future bone regeneration treatments.
AB - Bone tissue engineering has come on the scene to overcome the difficulties of the current treatment strategies. By combining biomaterials, active agents and growth factors, cells and nanomaterials, tissue engineering makes it possible to create new structures that enhance bone regeneration. Herein, hyaluronic acid and alginate were used to create biologically active hydrogels, and montmorillonite nanoclay was used to reinforce and stabilize them. The developed scaffolds were found to be biocompatible and osteogenic with mMSCs in vitro, especially those reinforced with the nanoclay, and allowed mineralization even in the absence of differentiation media. Moreover, an in vivo investigation was performed to establish the potential of the hydrogels to mend bone and act as cell-carriers and delivery platforms for SDF-1. Scaffolds embedded with SDF-1 exhibited the highest percentages of bone regeneration as well as of angiogenesis, which confirms the suitability of the scaffolds for bone. Although there are a number of obstacles to triumph over, these bioengineered structures showed potential as future bone regeneration treatments.
KW - 3D Scaffold
KW - Biomaterials
KW - Bone
KW - Nanoclay
KW - SDF-1
KW - Tissue Engineering
U2 - 10.1016/j.ijpharm.2022.121895
DO - 10.1016/j.ijpharm.2022.121895
M3 - Journal article
C2 - 35691524
AN - SCOPUS:85132520021
SN - 0378-5173
VL - 623
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
M1 - 121895
ER -